| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |